Qube Research & Technologies (QRT)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,431
Closed -$42K 3093
2022
Q3
$42K Sell
23,431
-2,749
-11% -$4.93K ﹤0.01% 2129
2022
Q2
$76K Buy
+26,180
New +$76K ﹤0.01% 2017
2021
Q4
Sell
-37,785
Closed -$322K 3115
2021
Q3
$322K Sell
37,785
-29,345
-44% -$250K ﹤0.01% 1456
2021
Q2
$1.1M Buy
67,130
+39,592
+144% +$650K 0.01% 891
2021
Q1
$608K Buy
+27,538
New +$608K 0.01% 1064